Jason Gorevic is the chief executive officer of Teladoc Health, a virtual healthcare delivery company.
Gorevic assumed the role of CEO in 2009 and has helped guide the company to become a world leader in virtual delivery of healthcare. He is noted for his passion for providing universal access to care and improving healthcare outcomes. Under his leadership, Teladoc has delivered millions of medical visits across 175 countries.
Before joining Teladoc Health, Gorevic was the chief sales and marketing officer of Empire BlueCross BlueShield. He was a key member of the leadership team that generated 20 percent growth in annual earnings per share, ultimately leading to 300 percent market cap growth between its 2002 IPO and its 2005 acquisition by WellPoint.
Gorevic continued to lead Empire BlueCross BlueShield under WellPoint, Inc. (now Anthem, Inc.) as president the chief marketing and product officer. He also became the president of the acquired Lumenos, Inc., driving enterprise-wide adoption of its consumer-directed health plan which became the company’s fastest-growing product.
The healthcare executive founded Gemfinity, an electronic marketplace and purchasing aggregator, in 2000. Before starting Gemfinity, Gorevic was the senior vice president of business messaging of Mail.com, a provider of Internet messaging services. He helped take the company public after growing it from 40 employees to 1,000.
Gorevic began his career with Oxford Health Plans in 1993 as the director of service strategy. He helped design and build a first generation telephone medical advice service staffed by Registered Nurses. This method of utilizing health care resources became industry standard.
He serves on the board of directors of New York Road Runners and holds a B.A. in international relations from the University of Pennsylvania.
What is Jason N. Gorevic's net worth?
The estimated net worth of Jason N. Gorevic is at least $6.08 million as of March 4th, 2024. Gorevic owns 653,073 shares of Teladoc Health stock worth more than $6,080,110 as of November 21st. This net worth evaluation does not reflect any other investments that Gorevic may own. Learn More about Jason N. Gorevic's net worth.
How do I contact Jason N. Gorevic?
Has Jason N. Gorevic been buying or selling shares of Teladoc Health?
Jason N. Gorevic has not been actively trading shares of Teladoc Health during the last quarter. Most recently, Jason N. Gorevic sold 53,755 shares of the business's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a transaction totalling $780,522.60. Following the completion of the sale, the chief executive officer now directly owns 653,073 shares of the company's stock, valued at $9,482,619.96. Learn More on Jason N. Gorevic's trading history.
Who are Teladoc Health's active insiders?
Teladoc Health's insider roster includes Michelle Bucaria (Insider), Karen Daniel (Director), Sandra Fenwick (Director), William Frist (Director), Arnnon Geshuri (Insider), Jason Gorevic (CEO), Claus Jensen (Insider), Laizer Kornwasser (President, Enterprise Growth and Global Markets), Lewis Levy (Insider), Mala Murthy (CFO), Richard Napolitano (CAO), Kenneth Paulus (Director), Vidya Raman-Tangella (Insider), David Shedlarz (Director), David Sides (COO), Hemant Taneja (Director), Daniel Trencher (SVP), Andrew Turitz (SVP), Adam Vandervoort (Insider), Stephany Verstraete (CMO), Yulun Wang (Insider), and Michael Waters (COO). Learn More on Teladoc Health's active insiders.
Are insiders buying or selling shares of Teladoc Health?
During the last year, Teladoc Health insiders bought shares 2 times. They purchased a total of 11,000 shares worth more than $83,750.00. During the last year, insiders at the health services provider sold shares 38 times. They sold a total of 266,139 shares worth more than $3,768,176.90. The most recent insider tranaction occured on September, 12th when Director Thomas Mckinley bought 4,000 shares worth more than $30,760.00. Insiders at Teladoc Health own 1.0% of the company.
Learn More about insider trades at Teladoc Health. Information on this page was last updated on 9/12/2024.